| Literature DB >> 28637176 |
Michael F Salvatore1, Jennifer Terrebonne2, Mark A Cantu1, Tamara R McInnis1, Katy Venable2, Parker Kelley2, Ella A Kasanga1, Brian Latimer3, Catherine L Owens3, Brandon S Pruett3, Yongmei Yu2, Robert Luedtke1, Michael J Forster1, Nathalie Sumien1, Donald K Ingram2.
Abstract
The escalating increase in retirees living beyond their eighth decade brings increased prevalence of aging-related impairments, including locomotor impairment (Parkinsonism) that may affect ~50% of those reaching age 80, but has no confirmed neurobiological mechanism. Lifestyle strategies that attenuate motor decline, and its allied mechanisms, must be identified. Aging studies report little to moderate loss of striatal dopamine (DA) or tyrosine hydroxylase (TH) in nigrostriatal terminals, in contrast to ~70%-80% loss associated with bradykinesia onset in Parkinson's disease. These studies evaluated the effect of ~6 months 30% calorie restriction (CR) on nigrostriatal DA regulation and aging-related locomotor decline initiated at 12 months of age in Brown-Norway Fischer F1 hybrid rats. The aging-related decline in locomotor activity was prevented by CR. However, striatal DA or TH expression was decreased in the CR group, but increased in substantia nigra versus the ad libitum group or 12-month-old cohort. In a 4- to 6-month-old cohort, pharmacological TH inhibition reduced striatal DA ~30%, comparable with decreases reported in aged rats and the CR group, without affecting locomotor activity. The dissociation of moderate striatal DA reduction from locomotor activity seen in both studies suggests that aging-related decreases in striatal DA are dissociated from locomotor decline.Entities:
Keywords: Bradykinesia; Parkinsonism; Parkinson’s disease; Striatum; Substantia nigra
Mesh:
Substances:
Year: 2017 PMID: 28637176 PMCID: PMC5861909 DOI: 10.1093/gerona/glx119
Source DB: PubMed Journal: J Gerontol A Biol Sci Med Sci ISSN: 1079-5006 Impact factor: 6.053